BeStock  
Stocks › GLUE

Monte Rosa Therapeutics GLUE

US equityMarket cap rank #3349
$8.64 −$0.27 (-3.03%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $8.64 0.00%
Open$8.73
Prev close$8.91
Day range$8.48 – $9.04
Volume2.52M
Market cap$738.29M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts8
Average target$25.14+191.0% vs. price
  • Buy 100%
Low $15.00Now $8.64Avg $25.14High $37.00

Recent rating changes

The last 20 actions on file set price targets from $15.00 to $37.00, averaging $27.41.

DateFirmRatingTarget
10 Nov 2026 Piper Sandler BUY $37.00
6 Nov 2026 Wells Fargo BUY $25.00
6 Nov 2026 Wedbush BUY $27.00
6 Nov 2026 H.C. Wainwright BUY $25.00
5 Nov 2026 Jefferies BUY $15.00
5 Nov 2026 Guggenheim BUY $28.00
12 Oct 2026 UBS BUY $19.00
5 Oct 2026 H.C. Wainwright BUY $25.00
2 Oct 2026 LifeSci Capital BUY –
2 Oct 2026 Piper Sandler BUY $37.00
2 Oct 2026 Wedbush BUY $27.00
1 Oct 2026 Guggenheim BUY $28.00
1 Oct 2026 H.C. Wainwright BUY $25.00
8 Sep 2026 LifeSci Capital BUY –
8 Sep 2026 Guggenheim BUY $28.00
24 Aug 2026 Guggenheim BUY $28.00
12 Aug 2026 Guggenheim BUY $28.00
10 Aug 2026 J.P. Morgan BUY $27.00
7 Aug 2026 Piper Sandler BUY $37.00
6 Aug 2026 LifeSci Capital BUY –

Discussion

No comments yet — be the first to weigh in on GLUE.

Sign in to join the discussion.

Scroll to Top